USPH Pretax Profit Margin from 2010 to 2024

USPH Stock  USD 97.08  1.52  1.54%   
US Physicalrapy's Pretax Profit Margin is decreasing with slightly volatile movements from year to year. Pretax Profit Margin is estimated to finish at 0.09 this year. For the period between 2010 and 2024, US Physicalrapy, Pretax Profit Margin quarterly trend regression had mean deviation of  0.03 and range of 0.0962. View All Fundamentals
 
Pretax Profit Margin  
First Reported
2010-12-31
Previous Quarter
0.08163994
Current Value
0.088
Quarterly Volatility
0.03190198
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check US Physicalrapy financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among US Physicalrapy's main balance sheet or income statement drivers, such as Interest Expense of 9.8 M, Total Revenue of 635 M or Gross Profit of 117.6 M, as well as many indicators such as Price To Sales Ratio of 2.99, Dividend Yield of 0.0194 or PTB Ratio of 4.71. USPH financial statements analysis is a perfect complement when working with US Physicalrapy Valuation or Volatility modules.
  
Check out the analysis of US Physicalrapy Correlation against competitors.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.

Latest US Physicalrapy's Pretax Profit Margin Growth Pattern

Below is the plot of the Pretax Profit Margin of US Physicalrapy over the last few years. It is US Physicalrapy's Pretax Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in US Physicalrapy's overall financial position and show how it may be relating to other accounts over time.
Pretax Profit Margin10 Years Trend
Slightly volatile
   Pretax Profit Margin   
       Timeline  

USPH Pretax Profit Margin Regression Statistics

Arithmetic Mean0.12
Geometric Mean0.12
Coefficient Of Variation25.60
Mean Deviation0.03
Median0.14
Standard Deviation0.03
Sample Variance0
Range0.0962
R-Value(0.31)
Mean Square Error0.001
R-Squared0.1
Significance0.26
Slope(0)
Total Sum of Squares0.01

USPH Pretax Profit Margin History

2024 0.088
2023 0.0816
2022 0.1
2018 0.13
2017 0.0815
2016 0.11

About US Physicalrapy Financial Statements

Investors use fundamental indicators, such as US Physicalrapy's Pretax Profit Margin, to determine how well the company is positioned to perform in the future. Although US Physicalrapy's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.08  0.09 

Currently Active Assets on Macroaxis

When determining whether US Physicalrapy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of US Physicalrapy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Us Physicalrapy Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Us Physicalrapy Stock:
Check out the analysis of US Physicalrapy Correlation against competitors.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of US Physicalrapy. If investors know USPH will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about US Physicalrapy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.24)
Dividend Share
1.75
Earnings Share
0.88
Revenue Per Share
42.489
Quarterly Revenue Growth
0.12
The market value of US Physicalrapy is measured differently than its book value, which is the value of USPH that is recorded on the company's balance sheet. Investors also form their own opinion of US Physicalrapy's value that differs from its market value or its book value, called intrinsic value, which is US Physicalrapy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because US Physicalrapy's market value can be influenced by many factors that don't directly affect US Physicalrapy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between US Physicalrapy's value and its price as these two are different measures arrived at by different means. Investors typically determine if US Physicalrapy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, US Physicalrapy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.